CN

CN
>

WuXi AppTec to Showcase Scientific Expertise at AACR 2021 - Join us!

WuXi AppTec is excited to showcase our scientific expertise during this year's AACR Annual Meeting, April 10-15, 2021. The AACR Annual Meeting covers the latest discoveries across the full spectrum of cancer research, highlighting the work of the best minds in research and medicine from institutions all over the world.

Attend our poster presentations, and visit our virtual exhibition to get your urgent oncology drug discovery questions answered by our experienced scientists. Pre-arrange your one-on-one meeting with our team here or email Wendy Liu directly at wendy_liu@wuxiapptec.com. 

 

ePoster Presentations

Title

Session Category

Abstract Number

E-poster Presentation

Presenter/Author

Myeloid-dominated spontaneous tumor models as the tool for the evaluation of immune modulators

Immunology

1654

April 10

(8:30am- 11:59pm)

Xuzhen Tang

Tumor evolution selectively inactivates microRNA machinery for immune evasion

Tumor Biology

3140

April 10

(8:30am- 11:59pm)

Haixin Zhao

Establishment of KRAS-G12C inhibitor induced resistant tumor models enable the development of new generation KRAS-G12C inhibitors and combinatorial strategies

Tumor Biology

2959

April 10

(8:30am- 11:59pm)

Gaoxiang Liu

Establishment and Optimization of scRNASeq assay to find the mechanism of immune therapy against tumors

Tumor Biology

2721

April 10

(8:30am- 11:59pm)

Qiyao Zhang

Engineered cell line panel complemented with in vivo models to enable next-generation target therapy discovery in cancer

Experimental and Molecular Therapeutics

1118 

April 10

(8:30am- 11:59pm)

Zhixiang Zhang

Establishment of KRAS G12C mutant patient-derived xenograft (PDX) models for pre-clinical evaluation of KRAS G12C targeted anticancer therapy

Tumor Biology

3004

April 10

(8:30am- 11:59pm)

Wenting Shi

Establishment of in vitro human T cell exhaustion model to enable high throughput target validation for T cell phenotype restoring

Tumor Biology

2774

April 10

(8:30am- 11:59pm)

Tienan Wang 

Siglec-15 knockout inhibits tumor growth in mouse model

Immunology

1634

April 10

(8:30am- 11:59pm)

Peixue Li

Identification of Tofacitinib, Filgotinib and Ruxolitinib on experimental Sjögren’s syndrome model in mice

Experimental and Molecular Therapeutics

1036

April 10

(8:30am- 11:59pm)

Ruiqing Yan

Validation of GVHD in humanized mouse model for preclinical efficacy screen

Immunology

1694

April 10

(8:30am- 11:59pm)

Yingying Cai

Cancer driver screens identify regulators of immune checkpoint blockade therapy response

 Immunology

1600

April 10

(8:30am- 11:59pm)

Wenrong Zhou

Drug induced resistant tumor models enable the development of next-generation anticancer therapeutics

Tumor Biology

2958

April 10

(8:30am- 11:59pm)

Ting Ni

 

Download our oncology literature here:

Oncology Services Introduction Brochure

Immuno-Oncology Platform

CRISPR/CAS9 Gene Editing